Equity Research, Broker Reports, and media content on Salvarx Group

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Salvarx Group
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Salvarx Group

Company Profile

  • Personnel
  • Denham Hervey Newall Eke, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Salvarx Group. We currently have 24 research reports from 3 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 17.5/44.5p
  • Daily Volume: N/A
  • Daily Liquidity: 0.0%
  • # Shares: 0m
  • Market Cap: £6.74m
  • Latest PE (hist): 4.25
  • Div Yield:
Date Source Announcement
09Jan20 14:30 RNS Cancellation of trading on AIM
20Dec19 10:30 RNS Cancellation of AIM listing /Potential acquisition
27Sep19 11:07 RNS Half-year Report - Correction
26Sep19 14:06 RNS Half-year Report
23Sep19 15:02 RNS AIM Rule 17 Notification
09Jul19 07:30 RNS Suspension of Trading
09Jul19 07:30 RNS Suspension - SalvaRx Group Plc
  • Frequency of research reports

     

  • Research reports on

    Salvarx Group

  • Providers covering

    Salvarx Group